BROWSE TOPICS IN CLINICAL MANAGEMENT:

Hepatitis C Research

Show Archived (Historical) Articles

Literature Citations for the Incidence and Diagnosis of HIV/Hepatitis C Coinfection (Regularly Updated)
From U.S. National Institutes of Health
Literature Citations for the Treatment of HIV/Hepatitis C Coinfection (Regularly Updated)
From U.S. National Institutes of Health
HCV Survival in Syringes Affected by Syringe Type, Time and Temperature (March 3, 2010)
A discussion with Elijah Paintsil, M.D., F.A.A.P.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Successful Hepatitis C Treatment Reduces HIV Disease Progression and Non-Liver-Related Mortality (February 22, 2010)
From aidsmap.com
Chronic HIV and HCV Swell Stroke Risk in Veterans Aging Cohort (February 20, 2010)
From National AIDS Treatment Advocacy Project
Hepatitis C Virus Can Survive in Syringes for Up to 63 Days (February 20, 2010)
From aidsmap.com
Detachable Needles on Syringes Promote Hepatitis C Transmission, Study Says (February 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Meta-Analysis: Increased Mortality Associated With Hepatitis C in HIV-Infected Persons Is Unrelated to HIV Disease Progression (January 13, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Researchers Find Genetic Explanation for Why Hepatitis C (HCV) Treatment Doesn't Work for Some (January 6, 2010)
From The Body
Sexual Transmission of Hepatitis C Happens Through Blood, Not Semen, in Gay Men With HIV, Study Says (November 17, 2009)
From The Body
U.S.: 1 in 12 Truckers Has Hepatitis C (November 12, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
A Few Coffees a Day Keep Liver Disease at Bay: Study (October 26, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Risk of Developing Specific AIDS-Defining Illnesses in Patients Co-Infected With HIV and Hepatitis C Virus With or Without Liver Cirrhosis (October 5, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Men's Sex Lives May Suffer on Hepatitis C Therapy (September 22, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Both Hepatitis C Drugs Work About the Same: Study (August 11, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Sustained Response to Interferon Improves Fibrosis in HIV/HCV-Coinfected Patients (July 23, 2009)
HIV-infected people who achieve a sustained virological response to hepatitis C treatment using pegylated interferon plus ribavirin may experience regression of fibrosis and even cirrhosis, according to study findings.
From aidsmap.com
Study Confirms International Outbreak of Sexually Transmitted Hep C (June 5, 2009)
In CATIE News, from Canadian AIDS Treatment Information Exchange
Hepatitis C Transmission Among HIV-Infected Men Who Have Sex With Men Is Occurring Primarily in Men Older Than 35 (February 11, 2009)
An interview with Sarah Fishman.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Hepatitis C Ups Liver Cancer Risk, Study Confirms (January 20, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Hepatitis C Coinfection May Increases Heart Attack, Stroke Risk, Study Finds (August 12, 2008)
In aidsmap.com
New Theory Suggests How Hepatitis C May Cause Rare Immune Disease (May 9, 2008)
From Rockefeller University
Hepatitis C: New Treatments in the Pipeline (April 2008)
To read PDF, click here.
From Treatment Action Group
CROI: Choice of Nucleoside Analogue in Co-Infection: Tenofovir Associated With Better Response to HCV Therapy (February 15, 2008)
From aidsmap.com
Study Examines Pro-Inflammatory Responses in HIV/HCV-Coinfected Injection Drug Users (February 6, 2008)
From The Body PRO
Higher HCV RNA Levels Associated With Greater Early T-Cell Activation and CD4+ Cell Depletion Among Antiretroviral-Naive, HIV/HCV-Coinfected Patients (February 5, 2008)
From The Body PRO
HIV/HCV-Coinfected Patients Appear More Likely Than HIV-Monoinfected Patients to Develop Insulin Resistance After Initiating HAART (February 5, 2008)
From The Body PRO
HIV/Hepatitis C Coinfection Does Not Influence CD4+ Cell Recovery in Patients on Suppressive HAART (February 5, 2008)
Lars Peters, M.D., discusses his study, which counters long-established assumptions about the effect of HCV/HIV coinfection on immune recovery after patients commence antiretroviral therapy.
From The Body PRO
Rapid Liver Fibrosis Occurring More Frequently Among HIV-Infected Men Newly Coinfected With Hepatitis C (February 4, 2008)
An interview with Daniel Fierer, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Daily Cannabis Use Associated With Worse Fibrosis in Patients With Chronic Hepatitis C (January 29, 2008)
From aidsmap.com
CD4 Cell Count Is No Predictor of Hepatitis C Treatment Success (January 18, 2008)
From aidsmap.com
First Large Head-to-Head Comparison of Schering and Roche HCV Therapies: Similar Virologic Responses; Fewer Relapses With PegIntron (January 16, 2008)
From aidsmap.com
EACS: Studies Underline the Need for Better Hepatitis C Treatment (November 2, 2007)
From aidsmap.com
Undetectable Viral Load Is Goal for All, Together With Earlier Treatment, Say New European Treatment Guidelines (October 25, 2007)
From aidsmap.com
News From the Front (Fall 2007)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
Routine Hepatitis C Screening Urged for Patients Diagnosed With HIV: Study (September 27, 2007)
In aidsmap.com
Testing Method Could Predict Sustained Virologic Response to HCV Treatment at Four Weeks (August 15, 2007)
From Reuters Health
Rapid and Early Virological Response to Chronic Hepatitis C Treatment With IFN Alpha-2b or PEG-IFN Alpha-2b Plus Ribavirin in HIV/HCV Coinfected Patients (August 2007)
In Gut
SMART Substudy on Hepatitis Coinfection (July 24, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
Hepatitis C Treatment (July 23, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
Sexual Transmission of Hepatitis C (July 23, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
Early HCV Treatment Is Usually Successful in HIV/HCV-Coinfected Gay Men (July 11, 2007)
From aidsmap.com
Study May Disprove Link Between HIV/Hep C Coinfection and Some Metabolic Problems (May 21, 2007)
A pair of new U.S. studies appears to contradict long-held concerns that HIV/hepatitis C-coinfected people have a higher risk of diabetes and lipoatrophy (fat loss).
From aidsmap.com
Acute Hepatitis C Infection in HIV-Infected Men: An Emerging Epidemic (May 2007)
A detailed discussion by Mark Danta, M.D., M.P.H., of the University of New South Wales Australia.
In The PRN Notebook
HCV Relapse Common, Treatment Success Uncertain Following Liver Transplant in HIV/HCV-Coinfected Patients (January 12, 2007)
From aidsmap.com
Cardiovascular Disease Risk Higher Among HIV/HCV-Coinfected Patients (January 11, 2007)
In AIDS
Lipid Abnormalities in HIV/Hepatitis C Virus-Coinfected Patients (November 2006)
In HIV Medicine
redirect --> http://www.washingtonpost.com/wp-dyn/content/article/2006/09/12/AR2006091201444.html (September 13, 2006)
In The Washington Post
HIV/HCV Coinfection Exacerbates ESLD Risk (September 2006)
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
Advocacy Groups Charge Schering-Plough With Racial Discrimination for Excluding Blacks From Hepatitis C Trial (April 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Chronic Hepatitis C in the Hispanic Population (March 2006)
To read PDF, click here.
From HCV Advocate
Literature Review: Hospitalizations, Expenditures Due to Hepatitis C on the Rise in U.S. (January 2006)
In Infectious Diseases in Corrections Report, from Brown Medical School
Study Finds Epoetin Alfa Improves Anemia in HIV/HCV-Coinfected Patients (August 2005)
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care

The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.